EGPA.

Slides:

Advertisements

Similar presentations

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Advertisements

Moderate-to-Severe Asthma Management

Systemic Lupus Erythematosus

Clinical Trials in IBD.

Psoriatic Arthritis.

A Review of the Critical Role of Imaging in Primary Liver Malignancy

Why Gene Therapy for Hemophilia?

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.

Unraveling Clinical Developments in NASH

Advances in Managing Inhibitors in Patients With Hemophilia A

Pseudomonas Lung Infections in Cystic Fibrosis

Progression After Cancer Immunotherapy in Advanced NSCLC

Chronic Rhinosinusitis

Ask the Onychomycosis Expert, Part 1

Case Challenges in Chronic Migraine

Updates in Management of Atopic Dermatitis From Real Patient Cases

Advances in Dry Eye.

The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy.

Induction Chemotherapy for Patients With High-Risk or Secondary AML

The Resurgence of Topical Treatments Across a Spectrum of Psoriasis

Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.

Chronic Idiopathic Urticaria

Emerging Targeted Agents for Relapsed/Refractory Non-Hodgkin Lymphoma

Addressing Disease Burden in Asthma

Asthma and Atopic Comorbidities

The Evolving Role of Immunotherapy in NSCLC

Optimizing Management of Advanced Bladder Cancer

A Frontline Clinician's Guide to Managing Opioid-Induced Constipation

Multidisciplinary Perspectives on Interstitial Lung Diseases

Nontuberculous Mycobacterial Lung Disease

The Emerging Role of Immunotherapy in Hodgkin Lymphoma

Next-Gen Psoriasis Therapies:

Hyperhidrosis Is Burdensome!

Gene Therapy: Past, Present, and Future

Tackling Atopic Dermatitis

Ask the Experts.

Immunotherapy for cSCC

Perspectives on the Impact of Inflammation in OA

Battling Constipation

Updates in Neurogenic Orthostatic Hypotension

New Recommendations on How to Stage Hidradenitis Suppurativa

New Data on Emerging Treatments for Psoriasis

When Is Biologic Therapy Appropriate for HS?

Improving Outcomes in Psoriatic Arthritis

Personalizing Management in the Care of Patients With Advanced Sarcoma

Developments in the Wet AMD Treatment Landscape

Talking With Your Patients About Excessive Sweating

Getting to Grips With the Science of CGRP and Migraine

Advances in Severe Asthma Management

Guide to Atopic Dermatitis

Challenges in Severe Asthma

The Burden of Psoriasis:

Achieving Asthma Control

Patient Questions and Expert Answers in Psoriasis:

Severe Asthma and Comorbidities

Optimizing Joint Health in Hemophilia

The Psychiatrist's Role in Tardive Dyskinesia

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.

Novel Concepts in the Management of RCC

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.

From Adjuvant to Metastatic in Melanoma

The Psychiatrist's Role in Tardive Dyskinesia

Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition

This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Pathophysiologic Targets of Allergic Asthma

Merging the Art and Science of Managing nOH in Clinical Practice

Immune Checkpoint Inhibitors in Lung Cancer

Foundations of Asthma.

Presentation transcript:

EGPA

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US.

Introduction What Is EGPA?

Diagnostic Criteria, Classification, and Definition of EGPA

Incorporating EGPA Definition and Criteria Into Practice

Clinical Presentation and Diagnosis of EGPA

The Three "Classic" Phases of EGPA

Diagnosing EGPA in Patients Taking Corticosteroids

Overcoming Challenges of Diagnosing EGPA

EGPA Is an ANCA-Associated Vasculitis

Significance of ANCA in EGPA

Eosinophils Play a Major Role in the Pathophysiology of EGPA

Management and Treatment of EGPA

Targeting IL-5 for the Treatment of EGPA

IL-5 Targeted Therapy for EGPA Mepolizumab

Steroid Reduction With Mepolizumab

Emerging Therapies

Multidisciplinary Team Approach

Longitudinal Assessment of EGPA

Concluding Remarks

Abbreviations